Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients W...

od Home, Philip D.
Wydane 2013

Validity of Meta-analysis in Diabetes: We Need to Be Aware of Its Limitations

od Home, Philip D.
Wydane 2013

Management of type 2 diabetes: NICE guidelines

od Sibal, Latika, Home, Philip D
Wydane w Clin Med (Lond) (2009)

Repeatability of measurements and sources of variability in tests of cardiovascular autonomic function

od Lawrence, Gillian P, Home, Philip D, Murray, Alan
Wydane 1992

Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes

od Sibal, Latika, Agarwal, Sharad C, Home, Philip D
Wydane 2011

The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease

od Sibal, Latika, Agarwal, Sharad C, Home, Philip D, Boger, Rainer H
Wydane 2010

Observational Study of the Association of First Insulin Type in Uncontrolled Type 2 Diabetes with Macrovascular and Microvascular Disease

od Hall, Gillian C., McMahon, Alex D., Carroll, Dawn, Home, Philip D.
Wydane 2012

Safety, Tolerability, and Efficacy of Insulin Aspart in People with Type 2 Diabetes, as Biphasic Insulin Aspart or with Basal Insulin: Findings from the Multinational, Non-Interven...

od Hajjaji, Issam, Shah, Siddharth, Li, Yuxiu, Prusty, Vinay, Benabbas, Youcef, Home, Philip D.
Wydane 2014

Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A...

od Bolli, Geremia B., Landgraf, Wolfgang, Bosnyak, Zsolt, Melas‐Melt, Lydie, Home, Philip D.
Wydane w Diabetes Obes Metab (2020)

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria

od Sibal, Latika, Agarwal, Sharad C, Schwedhelm, Edzard, Lüneburg, Nicole, Böger, Rainer H, Home, Philip D
Wydane 2009

Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus NPH Insulin during Pregnancy

od Lepercq, Jacques, Lin, Jay, Hall, Gillian C., Wang, Edward, Dain, Marie-Paule, Riddle, Matthew C., Home, Philip D.
Wydane 2012

Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)...

od Home, Philip D., Bergenstal, Richard M., Bolli, Geremia B., Ziemen, Monika, Rojeski, Maria, Espinasse, Melanie, Riddle, Matthew C.
Wydane w Diabetes Obes Metab (2017)

Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%

od Owens, David R., Landgraf, Wolfgang, Frier, Brian M., Zhang, Mei, Home, Philip D., Meneghini, Luigi, Bolli, Geremia B.
Wydane w Diabetes Obes Metab (2019)

Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes:...

od Bolli, Geremia B., Kerr, David, Thomas, Reena, Torlone, Elisabetta, Sola-Gazagnes, Agnès, Vitacolonna, Ester, Selam, Jean Louis, Home, Philip D.
Wydane 2009

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes:...

od Komajda, Michel, Curtis, Paula, Hanefeld, Markolf, Beck-Nielsen, Henning, Pocock, Stuart J, Zambanini, Andrew, Jones, Nigel P, Gomis, Ramon, Home, Philip D
Wydane 2008

Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management: Reflections From a Diabetes Care Editors’ E...

od Cefalu, William T., Buse, John B., Del Prato, Stefano, Home, Philip D., LeRoith, Derek, Nauck, Michael A., Raz, Itamar, Rosenstock, Julio, Riddle, Matthew C.
Wydane w Diabetes Care (2014)

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial

od Komajda, Michel, McMurray, John J.V., Beck-Nielsen, Henning, Gomis, Ramon, Hanefeld, Markolf, Pocock, Stuart J., Curtis, Paula S., Jones, Nigel P., Home, Philip D.
Wydane 2010

Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes

od Riddle, Matthew C., Bolli, Geremia B., Home, Philip D., Bergenstal, Richard M., Ziemen, Monika, Muehlen-Bartmer, Isabel, Wardecki, Marek, Vinet, Laetitia, Jeandidier, Nathalie, Yki-Järvinen, Hannele
Wydane w Diabetes Technol Ther (2016)

Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine

od Birkeland, Kåre I., Home, Philip D., Wendisch, Ulrich, Ratner, Robert E., Johansen, Thue, Endahl, Lars A., Lyby, Karsten, Jendle, Johan H., Roberts, Anthony P., DeVries, J. Hans, Meneghini, Luigi F.
Wydane 2011

Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors’ Expert Forum

od Cefalu, William T., Bray, George A., Home, Philip D., Garvey, W. Timothy, Klein, Samuel, Pi-Sunyer, F. Xavier, Hu, Frank B., Raz, Itamar, Van Gaal, Luc, Wolfe, Bruce M., Ryan, Donna H.
Wydane w Diabetes Care (2015)